From pandemic suspect to the postvaccine era: The Haemophilus influenzae story

Clinical Infectious Diseases

Volumn 44, Issue 6, 2007, Pages 817-819

  Schuchat, Anne ^a   Messonnier, Nancy Rosenstein ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CEREBROSPINAL FLUID BARRIER; CHILDHOOD DISEASE; HAEMOPHILUS INFLUENZAE; HISTORY OF MEDICINE; HUMAN; NOTE; PANDEMIC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VACCINE PRODUCTION;

DISEASE OUTBREAKS; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS VACCINES; HUMANS; INCIDENCE; MALE; PROGNOSIS; SURVIVAL RATE; VACCINATION;

EID: 33847680113     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/511886     Document Type: Note

References (20)

1. Barry J. The great influenza: the epic story of the deadliest plague in history. New York: Viking Penguin, 2004.
2. Dworkin MS, Park L, Borchardt SM. The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons ≥65 years. Clin Infect Dis 2007; 44:810-6.
3. Centers for Disease Control and Prevention. Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 1991; 40:1-7.
4. Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b disease in the Hib vaccine era. JAMA 1993; 269:221-6.
5. Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b disease among infants and children: United States, 1987-1997. MMWR Morb Mortal Wkly Rep 1998; 47:993-8.
6. Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995. N Engl J Med 1997; 337:970-6.
7. Mulholland K, Hilton S, Adegbola R, et al. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997; 349:1191-7.
8. Levine OS, Lagos R, Munoz A, et al. Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b. Pediatr Infect Dis J 1999; 18:1060-4.
9. Gessner B, Sutanto A, Linehan M, et al. The incidence of vaccine-preventable Haemophilus influenzae type b on pneumonia and meningitis in Indonesian children using a hamlet-randomised vaccine probe design. Lancet 2005; 365:43-52.
10. Adegbola RA, Secka O, Lahai G, et al. Elimination of Haemophilus influenzae type b (Hib) disease from the Gambia after the introduction of routine immunization with a Hib conjugate vaccine: a prospective study. Lancet 2005; 366:144-50.
11. Daza P, Banda R, Misoya K, et al. The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence. Vaccine 2006; 24:6232-9.
12. Cowgill KD, Ndiritu M, Nyiro J, et al. Effectiveness of Haemophilus influenzae type b conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA 2006; 296:671-8.
13. von Gottberg A, de Gouveia L, Madhi SA, et al. Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa. Bull World Health Organ 2006; 84:811-8.
14. World Health Organization. WHO position paper on Haemophilus influenzae type b conjugate vaccines. Bull World Health Organ 2006; 81:445-52.
15. D'Ancona F, Salmaso S, Barale A, et al. Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy. Vaccine 2005; 23:2494-500.
16. Centers for Disease Control and Prevention. Serotyping discrepancies in Haemophilia influenzae type b disease: United States, 1998-1999. MMWR Morb Mortal Wkly Rep 2002; 51:706-7.
17. Ribeiro GS, Reis JN, Cordeiro SM, et al. Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil. J Infect Dis 2003; 187:109-16.
18. Adderson EE, Byington CL, Spencer L, et al. Invasive serotype a Haemophilus influenzae infections with a virulence genotype resembling Haemophilus influenzae type b: emerging pathogen in the vaccine era? Pediatrics 2001; 108:E18.
19. Pai R, Moore MR, Pilishvili T, et al. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis 2005; 191:1988-95.
20. Flannery B, Heffernan RT, Harrison LH, et al. Changes in invasive pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med 2006; 144:1-9.